Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL770254 | 0.85 | USP2 (0.39) | USP2LPAR5SMN1; SMN2KDM4EDUSP3 | |
| Ammonia Solution, Strong SCHEMBL14482726 | 0.84 | USP2 (0.38) | USP2LPAR5SMN1; SMN2KDM4EDUSP3 | |
| Phosphoric Acid SCHEMBL3926567 | 0.78 | USP2 (0.43) | USP2LPAR5SMN1; SMN2KDM4EDUSP3 | |
| SCHEMBL8722298 | 0.76 | CA1 (0.37) | — | |
| SCHEMBL8664208 | 0.72 | SMN1; SMN2 (0.43) | USP2LPAR5SMN1; SMN2KDM4EDUSP3 | |
| SCHEMBL30754 | 0.71 | LMNA (0.53) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL1638881 | 0.71 | LMNA (0.53) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL17165664 | 0.70 | LPAR1 (0.46) | USP2LPAR5 | |
| SCHEMBL3334101 | 0.70 | USP2 (0.45) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL2893437 | 0.69 | LPAR5 (0.54) | USP2LPAR5SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012024233-A2 | ZWITTERIONIC LIPIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-02-23 | — | — | WO | disclosed |